Boston Scientific number of employees

Boston Scientific reported 59,000 employees at December 31, 2025 in its latest annual report, up 6,000 (11.3%) on the year before. That compares with 41,000 at December 31, 2021. Revenue per employee was $340,237.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2025	59,000	+6,000 (11.3%)	$340,237	10-K, filed February 17, 2026
December 31, 2024	53,000	+5,000 (10.4%)	$315,981	10-K, filed February 18, 2025
December 31, 2023	48,000	+3,000 (6.7%)	$296,667	10-K, filed February 20, 2024
December 31, 2022	45,000	+4,000 (9.8%)	$281,822	10-K, filed February 23, 2023
December 31, 2021	41,000	—	$289,951	10-K, filed February 23, 2022

What the annual reports say

As of December 31, 2025, we had approximately 59,000 employees, of which approximately 60 percent were outside the U.S. 2025 annual report
As of December 31, 2024, we had approximately 53,000 employees, of which approximately 60 percent were outside the U.S. 2024 annual report
As of December 31, 2023, we had approximately 48,000 employees, of which approximately 58 percent were outside the U.S. 2023 annual report
As of December 31, 2022, we had approximately 45,000 employees, of which approximately 56 percent were outside the U.S. 2022 annual report
As of December 31, 2021, we had approximately 41,000 employees, including approximately 16,000 in operations, 20,000 in selling, marketing, distribution and administration, and 5,000 in clinical, regulatory and research and development. 2021 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: BSX vs GEHC BSX vs SYK

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Boston Scientific's SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Boston Scientific.